Based on the 3 illustrated ALK-rearranged index cases out of our clinical routine, we aimed to analyze the prevalence of ALK rearrangements in a retrospective cohort of 436 neuroendocrine tumors of the lung, including LCNEC, SCLC, TCs, and ACs. This evidence concerns the gene ALK and neuroendocrine neoplasm.